Investment
Bioindustry Fund I
Product
Advanced cellulosic materials, including Microcrystalline Cellulose (MCC) utilising patented AaltoCellTM Technology
Use
Various applications. For example, pulp-based fibres can be used in pharmaceuticals and nutraceuticals. They can replace plastic in the packaging industry as well as cotton and artificial fibres in the textile industry. In the construction industry, Microcrystalline Cellulose (MCC) can be used in insulation and paints, for example.
Impact
Nordic Bioproducts Group is Taaleri Bioindustry Fund I’s first Taxonomy aligned investment and contributes to the environmental objective of climate change mitigation. The company’s life cycle assessment showcases a 35–75% reduction in CO2 emissions compared to the Best Alternative Technologies (BAT), depending on the end-use of the MCC. The company also develops biomaterials that can substitute fossil-based materials in a wide range of applications such as binders, stabilisers and emulsifiers.
Our other investments
All Bioindustry Fund I-related carbon footprint calculations consider the full life cycle of the product. The values presented are based on third-party verified LCA calculations from which the data has been adjusted to the annual production volumes. The numbers presented have not been modified to account for the funds share of the carbon footprint, but they represent the total emissions. Only those values showing the fund’s share of the produced emissions are reported in the fund reports.
Carbon handprint is the amount of GHG that would have been emitted by the replaced product during the lifetime of the organisation’s product. The values presented are based on third party verified LCA calculations from which the data has been adjusted to annual production volumes. The numbers presented have not been modified to account for the funds share of the carbon handprint, but they represent the total avoided emissions. Only those values showing the fund’s share of the produced impact are reported in the fund reports.